Pulmonary Rehabilitation in Patients With Fibrotic Interstitial Lung Disease
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00415272
Our study aims to investigate the benefits of an outpatient pulmonary rehabilitation program in a population of subjects with fibrotic interstitial lung disease. Our hypothesis is that pulmonary rehabilitation will lead to improvements in quality of life, breathlessness, exercise capacity and pulmonary function in this patient population.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
Child, Adult, Senior
Sexes Eligible for Study:
Restriction on pulmonary function testing (TLC <80%, FEV1/FVC ratio > predicted or DLCO < 80%)
Evidence of fibrosis on high resolution computed tomography of the chest.
Fibrosis on surgical lung biopsy if performed
Referral for pulmonary rehabilitation
Participation in pulmonary rehabilitation in the past 24 months
Inability to complete 6 minute walk test or study questionnaires
Limitations other than dyspnea (e.g. arthritis) that affect ability to participate in pulmonary rehabilitation
Baseline 6 minute walk distance > 400 meters
Planned change in medication treatment for lung disease during the course of pulmonary rehabilitation
Ejection fraction known to be < 25%
Contraindications to pulmonary rehabilitation (clinically unstable, uncontrolled arrhythmia or hypertension, symptomatic or uncontrolled hypotension with systolic blood pressure of < 95, active angina, unexplained syncope or worsening dizziness, limiting orthopedic or neurological disorders, psychiatric impairment that inhibits cooperation in the program)